Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 7 , ISSUE 1 ( January-March, 2013 ) > List of Articles

REVIEW ARTICLE

Magnesium Sulfate: Fetal Neuroprotective Role in Reducing the Risk of Cerebral Palsy

Radu Vladareanu, Simona Constantinescu, Margareta Denes, Andrei Chilianu

Keywords : Cerebral palsy,Magnesium sulfate,Neuroprotection,Preterm birth

Citation Information : Vladareanu R, Constantinescu S, Denes M, Chilianu A. Magnesium Sulfate: Fetal Neuroprotective Role in Reducing the Risk of Cerebral Palsy. Donald School J Ultrasound Obstet Gynecol 2013; 7 (1):98-104.

DOI: 10.5005/jp-journals-10009-1275

License: CC BY-NC 4.0

Published Online: 01-12-2013

Copyright Statement:  Copyright © 2013; The Author(s).


Abstract

How to cite this article

Constantinescu S, Denes M, Chilianu A, Vladareanu R. Magnesium Sulfate: Fetal Neuroprotective Role in Reducing the Risk of Cerebral Palsy. Donald School J Ultrasound Obstet Gynecol 2013;7(1):98-104.


PDF Share
  1. Proposed definition and classification of cerebral palsy. Dev Med Child Neurol 2005;47(8):571-76.
  2. Long-term medical and social consequences of preterm birth. N Engl J Med 2008;359(3): 262-73.
  3. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008;359(9):895-905.
  4. Increasing prevalence of cerebral palsy among very preterm infants: A populationbased study. Pediatrics 2006; 118(6):1621-26.
  5. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: A systematic review and meta-analysis. Am J Obstet Gynecol 2009;200(6):595-609.
  6. Neuroprotective strategies for the neonatal brain. Anesth Analg 2008;106(6):1670-80.
  7. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants. Obstet Gynecol Clin North Am 2011; 38(2):351-66.
  8. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol 2003;102(3):628-36.
  9. Effect of magnesium sulfate given for neuroprotection before preterm birth: A randomized controlled trial. JAMA 2003;290(20):2669-76.
  10. Magnesium sulfate reduces inflammation-associated brain injury in fetal mice. Am J Obstet Gynecol 2010;202(3):292.e1-9.
  11. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: A meta-analysis. Obstet Gynecol 2009;114(2 Pt 1):354-64.
  12. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995; 95(2):263-69.
  13. Magnesium sulphate for fetal neuroprotection. Rev Bras Ginecol Obstet 2011;33(6): 265-70.
  14. The use of antenatal magnesium sulfate for neuroprotection for infants born prematurely. F1000 Med Rep 2010;2:78.
  15. Magnesium sulfate for preterm labor and preterm birth. Obstet Gynecol 2009;114(3):650-68.
  16. Magnesium sulfate in severe perinatal asphyxia: A randomized, placebo-controlled trial. Pediatrics 2009;123(5):764-69.
  17. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009(1):CD004661.
  18. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002;186(6):1111-18.
  19. The Magpie Trial: A randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG 2007;114(3):300-09.
  20. The Magpie Trial: A randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 2007;114(3):289-99.
  21. Magnesium sulphate given before very-preterm birth to protect infant brain: The randomised controlled PREMAG trial BJOG 2007;114(3):310-18.
  22. Benefit of magnesium sulfate given before very preterm birth to protect infant brain. Pediatrics 2008;121(1):225-26.
  23. Antenatal magnesium sulfate and neurologic outcome in preterm infants: A systematic review. Obstet Gynecol 2009;113(6):1327-33.
  24. Can magnesium sulphate provide neuroprotection in preterm infants? A literature review. RCSIsmj 2011;4(1): 46-52.
  25. Comittee Opinion No. 455. Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol 2010;115:669.
  26. Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child: National clinical practice guidelines. The University of Adelaide. 2010.
  27. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can 2011;33(5):516-29.
  28. Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: A decision-analytic and economic analysis. Am J Obstet Gynecol 2011;205(6):542.e1-7.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.